Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

August 12, 2024

Study Completion Date

April 16, 2025

Conditions
Diabetes
Interventions
DEVICE

Bulbicam

"The multi-test device, BulbiCam (BCAM), is a combined eye tracking; pupil metric; video graphic dual device which include the following 10 tests under development and ready for validation:~26 grids glaucoma screening perimetry 64 grids full perimetry (NeuroField64) Pupil and Relative Afferent Pupil Defect (RAPD) assessment Semi-automatic ptosis (droopy eyelid) grading Video-based nystagmus test Dynamic acuity and contrast sensitivity test Dark adaptation test Smooth pursuit eye movements Saccade movements Eye fixation stability BCAM is connected to the BulbiHub software where measured data is stored and presented in numbers, diagrams, and graphs."

Trial Locations (1)

0450

Oslo University Hospital, Oslo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Meddoc

OTHER

NCT06973694 - Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy | Biotech Hunter | Biotech Hunter